1_7 Sherry Rais: Social Impact, Psychedelic Therapy as Employee Benefit, and Finding Strength as a Female CEO
Sherry Rais, MSc, is the CEO of Enthea, a benefit plan administrator that provides health plan benefit riders and single case agreement services for psychedelic healthcare. She has helped dozens of startups, non-profit organizations, academic/research institutions, and small businesses raise funds, operate according to their mission and values, and implement processes that enhance their overall efficiency. Sherry believes in living and working in alignment with purpose and is currently focused on expanding access to psychedelic-assisted therapy to alleviate human suffering.
Before this, Sherry consulted for over 10 years with the United Nations and World Bank, implementing cash transfer programs at the national level in over 35 countries. Sherry holds a Master’s Degree in Public Policy and Management from the London School of Economics and a Bachelor’s Degree in Psychology and International Development from McGill University. She also completed the Certificate in Psychedelic Therapies and Research from CIIS in 2021. In addition to being Enthea's CEO, she is the Executive Director of the Boston Psychedelic Research Group and the Grants Manager for CIIS.
You can learn more about Enthea at https://www.enthea.com.